Serious Streptococcus pyogenes disease

Clinical Microbiology and Infection

Volumn 3, Issue 2, 1997, Pages 250-260

  Barnham, Michael ^a   Holm, Stig E ^b  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MEDICAL EDUCATION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

EID: 0030908783     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00606.x     Document Type: Article

References (85)

1. Barnham M, Weightman N, Chapman S, Efstratiou A, George R, Stanley J Two clusters of invasive Streptococcus pyogenes infection in England. In Horaud T, Sicard M, Bouvet A, de Moncclos H, eds. Streptococci and the host (Proceedings of the XIIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases). New York: Plenum Publishing Company, 1997: in press
2. Stevens DL. Invasive group A streptococcus infections. Clin Infect Dis 1992; 14: 2-13.
3. Musser JM. Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerging Infect Dis 1996; 2: 1-17.
4. Gaworzewska E, Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes Epidemiol Infect 1988; 100: 257-69.
5. Schwanz B, Facklam RR, Breiman RE Changing epidemiology of group A streptococcal infection in the USA. Lancet 1990; 336: 1167-71.
6. Cartwright K, Logan M, McNulty C, et al. A cluster of cases of necrotizing fasciitis in Gloucestershire. Epidemiol Infect 1995; 115: 387-97.
7. Demers B, Simor AE, Vellend H, et al. Severe invasive streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16: 792-800.
8. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 1990; 22 421-9.
9. Musser JM. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections. Pediatr Ann 1992; 21: 821-8.
10. Upton M, Carter PE, Morgan M, Edwards GF, Pennington TH. Clonal structure of invasive Streptococcus pyogenes in Northern Scotland. Epidemiol Infect 1995; 115: 231-41.
11. El-Bouri KW, Lewis AM. Wright D, Joynson DHM. An outbreak of invasive and non-invasive group A streptococcal disease in a town in South Wales caused by multiple serotypes. J Infect 1996; 32: 91.
12. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype Ml protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63: 994-1003.
13. Davies HD, McGeer A, Schwanz B, et al. Invasive group A streptococcal infections in Ontario, Canada. New Engl J Med 1996; 335: 547-54.
14. Hoge CW, Schwartz B, Talkington DF, Breiman RF, MacNeill EM, Englender SJ. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. JAMA 1993; 269: 384-9.
15. Stromberg A, Romanus V, Burman LG. Outbreak of group A streptococcal bacteraemia in Sweden: an epidemiologic and clinical study. J Infect Dis 1991; 164: 595-8.
16. Bucher A, Martin PR, Hoiby EA, et al. Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. EurJ Clin Microbiol Infect Dis 1992; 11: 416-26
17. Andersen MM, Ronne T. Group A streptococcal bacteraemias in Denmark 1987-89. J Infect 1995; 31: 33-7.
18. Jepson AP. Infection ... by the new genetics. J Infect 1996; 33: 1-5.
19. Lancefield RC. Group A streptococcal infections in animalsnatural and experimental. In Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases. New York: Academic Press, 1972: 313-26.
20. Efstratiou A, Colman G, Crowley D, Pitcher D. Ribotyping of human pyogenic streptococci. In Orefici G. ed. New perspectives on streptococci and streptococcal infections. Stuttgart: Gustav Fischer Verlag, 1992: 90-1.
21. Fischetti VA. Srreptococcal M protein: molecular design and biological behavior. Clin Microb Rev 1989; 2: 285-314.
22. Stanley J, Linton D, Desai M, Efstratiou A, George R. Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease. J Clin Microbiol 1995; 33: 2850-5.
23. Norgren M, Norrby A, Holm SE. Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. J Infect Dis 1992; 166: 1014-20.
24. Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW. Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet 1980; ii: 498-502.
25. Pichichero ME. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Pediatr Infect Dis J 1991; 10: S50-5.
26. van Asselt GJ, Mouton RP, van Boven CPA. Penicillin tolerance and treatment failure in group A streptococcal pharyngotonsillitis. EurJ Clin Microbiol Infect Dis 1996; 15: 107-15.
27. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98: 326-35.
28. Stevens DL. Streptococcal toxic shock syndrome: spectrum of disease, pathogenesis and new concepts in treatment. Emerg Infect Dis 1995; 1: 69-77.
29. Stevens DL, Bryant AE, Hackett SP. Antibiotic effects on bacterial viability, toxin production and host response. Clin Infect Dis 1995; 20 (Suppl 2): S154-7.
30. Stevens DL, Yan S, Bryant AE. Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 1993; 167: 1401-5.
31. Barnham M. Streptococcal infection in general practice. Epidemiol Infect 1992; 109: 177-80.
32. Pollard AJ, Isaacs A, Lyall EGH, et al. Potentially lethal bacterial infection associated with varicella zoster virus. Br Med J 1996; 313: 283-5.
33. PHLS Working Group. Invasive group A streptococcal infections: second report of the PHLS enhanced surveillance scheme. Communicable Dis Rep Weekly, 1995; 5: 123-4.
34. Barnham M. Streptococci and the skin. In Noble WC, ed. The skin microflora and microbial skin disease. Cambridge; Cambridge University Press, 1993: 173-209.
35. Colman G, Tanna A, Efstratiou A, Gaworzewska ET. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993; 39: 165-78.
36. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. New Engl J Med 1989; 321: 1-7.
37. Francis J, Warren RE. Streptococcus pyogenes bacteraemia in Cambridge - a review of 67 episodes. QJ Med (New Series) 1988; 68: 603-13.
38. Jagdis J. Group A streptococcal meningitis and brain abscess. Pediatr Infect Dis J 1988; 7: 885-6.
39. Burkert T, Watanakunakorn C. Group A streptococcal endocarditis: report of five cases and review of the literature. J Infect 1991; 23: 307-16.
40. Giuliano A, Lewis F, Hadley K, Blaisdell FW. Bacteriology of necrotizing fasciitis. Am J Surg 1977; 134: 52-7.
41. Donaldson PMW, Naylor B, Lows JW, Gouldesbrough DR. Rapidly fatal necrotising fasciitis caused by Streptococcus pyogenes. J Clin Pathol 1993; 46: 617-20.
42. Chelsom J, Halstensen A, Haga T, Hoiby EA. Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet 1994; 344: 1111-15.
43. Talkington DF, Schwartz B, Black CM, et al. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61: 3369-74.
44. Janevicius RV, Hann S-E, Batt MD. Necrotizing fasciitis. Surg Gyn Obstet 1982; 154: 97-102.
45. Burge TS, Watson JD. Necrotising fasciitis. Br Med J 1994; 308: 1453-4.
46. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. New Engl J Med 1996; 334: 240-5.
47. Mathieu D, Neviere R, Teillon C, Chagnon JL, Lebleu N, Wattel F. Cervical necrotizing fasciitis: clinical manifestations and management. Clin Infect Dis 1995; 21: 51-6.
48. Aitken DR, Mackett MCT, Smith LL. The changing pattern of hemolytic streptococcal gangrene. Arch Surg 1982; 117: 561-7.
49. Working group on severe streptococcal infections. Defining the group A streptococcal toxic shock syndrome. JAMA 1993, 269: 390-1.
50. Wood TF, Potter MA, Jonasson O. Streptococcal toxic shock-like syndrome: the importance of surgical intervention. Ann Surg 1993; 217: 109-14.
51. Stevens DL. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin Infect Dis 1995; 21: 977-80.
52. Brun-Buisson CJL, Saada M, Trunet P, Rapin M. Haemolytic streptococcal gangrene and non-steroidal anti-inflammatory drugs. Br Med J 1985; 290-1786.
53. Rietveld JA, Pilmore HL, Jones PG, et al. Necrotising fasciitis: a single centre's experience. NZ Med J 1995; 108: 72-4.
54. Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser J, Rich RR. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun 1994; 62: 1867-74.
55. Norrby-Teglund A, Norgren M, Hohn SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxic factor, MF and the pyrogenic exotoxin A and B. Infect Immun 1994; 62: 3731-8.
56. Holm SE, Norrby A, Bergholm A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166: 31-7.
57. Stegmayr B, Bjorck S, Holm SE, Nisell J, Rydvall A, Settergren B. Septic shock induced by group A streptococcal infections: clinical and therapeutic aspects. ScandJ Infect Dis 1992; 24: 589-97.
58. Norrby-Teglund A, Kaul R, Low DE, et al. Plasma from patients with severe group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen- induced T cell proliferation and cytokine expression. J Immunol 1996; 156. 3057-64.
59. Alouf JE, Knoll H, Kohler W. In Alouf JE, Freer JH, eds. Sourcebook of bacterial protein toxins. London: Academic Press, 1991: 367-414.
60. Bartter T, Dascal A, Carroll K, Curley FJ. Toxic strep syndrome': a manifestation of group A streptococcal infection. Arch Intern Med 1988; 148: 1421-4.
61. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17: 251-72.
62. Stevens DL, Bryant AE, Hackett SP, et al. Group A streptococcal bacteraemia: the role of tumor necrosis factor in shock and organ failure. J Infect Dis 1996; 173: 619-26.
63. Sissons JGP. Superantigens and infectious disease. Lancet 1993; 341: 1627-8.
64. Murray DL, Ohlendorf DH, Schlievert PM. Staphylococcal and streptococcal superanngens: their role in human diseases. ASM News 1995; 61: 229-35.
65. Ferrieri P. Acute post-streptococcal glomerulonephritis and its relationship to the epidemiology of streptococcal infections. Minnesota Med 1975; 58: 598-602, 615.
66. Reid HFM, Thorne CD. Scabies infestation: the effect of intervention by public health education. Epidemiol Infect 1990, 105: 595-602.
67. Carapetis JR, Currie BJ. Impact of streptococcal pyoderma in Australian Aboriginal communities. In: Horaud T, Sicard M, Bouvet A, de Montclos H, eds. Streptococci and the host (Proceedings of the XIIIth Lancefield International Symposium on Streptococci and Streptococcal Diseases). New York: Plenum Publishing Company, 1997: in press.
68. Dillon HC Streptococcal infections of the skin and their complications: impetigo and nephritis. In: Wannamaker LW, Matsen JM, eds. Streptococci and streptococcal diseases: recognition, understanding and management. New York: Academic Press, 1972: 571-87.
69. Reid HFM, Bassett DCJ, Gaworzewska E, Colman G, Poon-King T. Streptococcal serotypes newly associated with epidemic post-streptococcal acute glomerulonephritis. J Med Microbiol 1990; 32: 111-14.
70. Stetson PA, Rammelkamp CH, Krause RM, Kohen RJ, Perry WD. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine 1955; 34: 431-50.
71. Gerber MA, Markowitz M. Management of streptococcal pharyngitis reconsidered. Pediatr Infect Dis J 1985; 4: 518-26.
72. Rodriguez-Iturbe B, Castillo L, Valbuena R, Cuenca L. Acute post-streptococcal glomerulonephritis: a review of recent developments. Pediatrician 1979; 8: 307.
73. Johnston KH, Zabriskie JB. Purification and partial characterization of the nephritis strain-associated protein from Streptococcus pyogenes, group A. J Exp Med 1986; 163: 697-712.
74. Cronin W, Deol, H, Azadegan A, Lange K. Endostreptosin: isolation of the probable immunogen of acute post-streptococcal glomerulonephritis. Clin Exp Immunol 1989; 76: 198-203.
75. Poon-King R, Bannan J, Viteri A, Cu G, Zabriskie JB. Identification of an extracellular plasmin binding protein from nephritogenic streptococci. J Exp Med 1993; 178: 759-63.
76. Barnham M, Thornton TJ, Lange K. Nephritis caused by Streptococcus zooepidemicus (Lancefield group C). Lancet 1983; i: 945-8.
77. Gnann JW, Gray BM, Griffin FM, Dismukes WE. Acute glomerulonephritis following group G streptococcal infection. J Infect Dis 1987; 156: 411-12.
78. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decrease in morbidity and mortality from rheumatic fever in the United States. New Engl J Med 1988; 318. 280-6.
79. Leading article. Decline in rheumatic fever. Lancet 1985; ii: 647-8.
80. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. New Engl J Med 1987; 316: 421-7.
81. Bisno AL. Group A streptococcal infections and acute rheumatic fever. New Engl J Med 1991; 325: 783-93.
82. Kaplan EL, Johnson DR, Cleary PP. Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis 1989; 159: 101-3.
83. Ayoub EM, Chun CSY. Non-suppurative complications of group A streptococcal infection. Adv Pediatr Infect Dis 1990; 5: 69-92.
84. Wannamaker LW, Ayoub EM. Antibody titers in acute rheumatic fever. Circulation 1960; 21: 598-614.
85. Carapetis JR, Currie BJ. Group A streptococcus, pyoderma and rheumatic fever. Lancet 1996; 347: 1271-2.